ABSTRACT Both estrogen-receptor (ER) positive MCF-7 and ER-negative Hs578T and MDA-MB-231 human breast cancer cells were treated with carotenoids (␤-carotene, canthaxanthin and lycopene) and retinoids (all-trans-, 9-cis-and 13-cis-retinoic acid and all-trans-retinol). Among carotenoids, ␤-carotene significantly reduced the growth of MCF-7 and Hs578T cells, and lycopene inhibited the growth of MCF-7 and MDA-MB-231 cells. Canthaxanthin did not affect the proliferation of any of the three cell lines. All-trans-and 9-cis-retinoic acid significantly reduced the growth of both MCF-7 and Hs578T cells, whereas 13-cis-retinoic acid and all-trans-retinol had a significant effect only on MCF-7 cells. MCF-7 and Hs578T cells treated with all-trans-retinoic acid (all-t-RA) were further studied for the mechanism behind growth inhibition. Retinoic acid receptors ␣ and ␥ (RAR␣, ␥) in MCF-7 cells and RAR␣, ␤ and ␥ in Hs578T cells were not induced by all-t-RA treatment at either the protein or mRNA level. Hs578T cells treated with all-t-RA had significantly more cells in the G0/G1 stage of the cell cycle, but the same was not observed for MCF-7 cells. All-t-RA induced a dose-dependent cell death in MCF-7 cells, which may be a necrotic phenomenon. These results demonstrate that ER status is an important, although not essential factor for breast cancer cell response to carotenoid and retinoid treatments, and the mode of action of all-t-RA in MCF-7 and Hs578T cells is not through the induction of RAR. Other mechanistic pathways that are either followed by or concomitant with growth inhibition are possible. J. Nutr. 131: 1574Nutr. 131: -1580Nutr. 131: , 2001.
Cancer of the breast is the most common incident cancer and cause of death from cancer in women (WHO 1997) . The offspring of emigrants from countries with low breast cancer incidence to countries with high breast cancer incidence acquire rates close to those of the new country, suggesting that environmental and lifestyle influences are important in the etiology of breast cancer (McMichael and Giles 1988) . This could be the result of noninherited factors including, among other possibilities, diet (Trichopoulos and Willett 1996) .
Epidemiologic and laboratory investigations exploring the relationship between diet and disease suggest an inverse correlation between consumption of fruits and vegetables rich in carotenoids and certain cancer incidence rates (Block et al. 1992 , Ziegler 1989 ). In a review of possible environmental determinants of cancer, it was estimated that 35% of cancers in the United States might be attributable to dietary factors . Several studies have shown that low levels of either dietary intake or plasma carotenoids are associated with an increased risk of breast cancer (Comstock et al. 1992 , Potischman et al. 1990 , Weisburger 1991 .
Carotenoids may act as chemoprotective agents through biological activities such as metabolism to retinoids, antioxidation, immunoenhancement, protection against cellular mutagenesis and malignant transformation, and inhibition of tumorigenesis (Bendich 1989 , Krinsky 1989 , Shultz et al. 1992 . Carotenoids also function as radical-trapping antioxidants in vitro and may have the same activity in vivo (Burton and Ingold 1984, Krinsky 1989) . Retinoids, on the other hand, exert a variety of effects on basic biological processes such as growth, differentiation, development and malignant transformation, in addition to receptor-induced signal transduction. Knowledge of the effect of these compounds has led to the hypothesis that retinoids may act as chemopreventive agents as well as inhibitors of the growth of established tumors (Hill and Grubbs 1992, Peto et al. 1981) .
This study was designed to determine the effects of carotenoids and retinoids on the growth of human breast cancer cells. Briefly, the growth of estrogen-receptor positive (ERϩ) 3 MCF-7 and estrogen-receptor negative (ERϪ) Hs578T and MDA-MB-231 human breast cancer cells was determined after 1 Supported in part by National Institutes of Health grant 5R01 CA 66914 -03 and by a fellowship from the Cancer Research Foundation of America. P.P. was supported by a fellowship from the Cancer Research Foundation of America.
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Cell proliferation. For the determination of cell proliferation, MCF-7, Hs578T and MDA-MB-231 cells were incubated with ␤-carotene, canthaxanthin, lycopene, all-trans-, 9-cis-and 13-cis-retinoic acid and all-trans-retinol solutions for up to 9 d. Proliferating viable cells attached to the plastic wells were harvested and their numbers counted on d 2, 5 and 9 (data are shown for d 9 only, i.e., when the cells reached confluency). For cell harvesting, the medium was aspirated from the wells; 0.5 mL of 0.25% trypsin solution was added to each well and incubated at 37°C for 5, 3 and 2 min, for MCF-7, MDA-MB-231 and Hs578T cells, respectively. The reaction was stopped with 1.5 mL of the growth medium at room temperature. The cells were collected and counted in duplicate using an electronic Coulter Counter (model Z1; Coulter, Miami, FL). Cell morphology was monitored by periodic evaluation of the cells under a phase contrast microscope throughout the experiments.
Northern blot analysis of RAR(␣, ␤ and ␥) mRNA expression. MCF-7 and Hs578T cells were incubated with all-t-RA for 2, 6, 8, 24 and 72 h. RAR␣, ␤ and ␥ expression was examined at the transcription level in the control and treatment cells by Northern blot analysis of total cellular RNA, which was extracted from the cells using the cesium chloride gradient method (Tsou et al. 1994) . RNA from each sample (30 g) was subjected to electrophoresis on a 1.2% agarose gel containing 5% formaldehyde. The gel was transferred to a Nytran Plus nylon membrane using a Turboblotter system (Schleicher & Schuell, Keene, NH). The membrane(s) were subjected to UV crosslinking and then hybridized to [␣- 32 P]-dCTP-labeled retinoid receptor cDNA probes (Tsou et al. 1994) . pHE7 was used as a control gene to monitor equivalent loading of RNA in each lane because the levels of pHE7 are not affected by retinoic acid (Tsou et al. 1994) . After high stringency washing (0.1X standard saline citrate at 60°C), the membranes were exposed to photographic film using an intensifying screen at Ϫ80°C for various lengths of time (between 1 and 7 d). The films were developed using an RG II film processor (Fuji, Elmsford, NY) .
Semiquantitative evaluation of Northern blots. The films of Northern blot analysis were quantified by densitometric scanning using a PD model densitometer (Molecular Dynamics, Sunnyvale, CA) and ImageQuant software. The pixel value obtained for each individual band was normalized to the value of its relative pHE7 expression. The values obtained after normalization were used to compare the expression of retinoid receptors against their respective controls in the cell lines at different time points. Data are expressed as fold induction, considering the value of the control to be 1.
Flow cytometry. MCF-7 and Hs578T cells were incubated with all-t-RA for 6 and 9 d. After exposure to experimental conditions, cells were collected and washed twice with cold PBS and suspended again in PBS. Absolute ethanol was added dropwise with vortexing at low speed to bring the ethanol concentration to 70%; this suspension was fixed at 4°C for 30 min. Cells were again washed twice with PBS after removal of ethanol and incubated with 10 mg/L RNase solution in PBS at 37°C for 30 min, with mixing several times during incubation. After being washed twice with PBS, cells were suspended in propidium iodide solution at 1 ϫ 10 6 cells/0.5 mL concentration. Cells were then analyzed for their cell cycle distribution using a Flow cytometer (Beckton Dickinson, Franklin Lakes, NJ) and ModFit LT 2.0 software (Beckton Dickinson) for data analysis.
Morphological analysis. MCF-7 cells were incubated with allt-RA for 7 d. Cells were grown on chamber slides for the morphologic analysis. After exposure to experimental conditions, cells were washed with PBS and stained with acridine orange (25 mg/L) and propidium iodide (25 mg/L) for 15 min in the dark. Cells were then washed in PBS, fixed in 10% formalin for 30 min in the dark and washed again in PBS. Dual-stained cells were viewed using a fluorescence microscope. Cells were coded as either early apoptotic (bright green, highly condensed chromatin), late apoptotic (bright orange, highly condensed chromatin) or necrotic cells (bright orange nucleus without condensed chromatin) (Broaddus et al. 1996) .
Statistics. Results are expressed as means Ϯ SD of three determinations. Comparisons of mean values of control and treatment cells were made using ANOVA on the whole population followed by two-sample Student's t test between control and each treatment group. The statistical significance of difference (P Ͻ 0.05) for the treatment groups was determined relative to their respective control group. Effect of retinoids on cell growth. The effects of all-trans-, 9-cis-and 13-cis-retinoic acid, dissolved in acetone (0.25%), on the growth of Hs578T cells are shown in Figure 2 . Alltrans-and 9-cis-retinoic acid significantly inhibited the growth of Hs578T cells at 100 nmol/L and 1 mol/L on d 9 (P Ͻ 0.05), whereas 13-cis-retinoic acid had no effect on cell growth. All-trans-retinol at 100 nmol/L and 1 mol/L significantly inhibited the growth of MCF-7 cells, stimulated the growth of MDA-MB-231 cells and had no effect on Hs578T cells on d 9 of treatment (P Ͻ 0.05; Fig. 3 ). Significant effects 
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FIGURE 2
Effect of all-trans-, 9-cis-and 13-cis-retinoic acid (RA), dissolved in acetone (0.25%), on the growth of Hs578T human breast cancer cells grown at a density of 5000 cells/cm 2 . Cells were treated with the retinoids at concentrations of 10 nmol/L, 100 nmol/L and 1 mol/L in the media for 9 d. Values are means Ϯ SD of three replicate assays; *significantly different from control, P Ͻ 0.05.
FIGURE 3
Effect of all-trans-retinol (all-t-ROL), dissolved in acetone (0.25%), on the growth of MCF-7, Hs578T and MDA-MB-231 human breast cancer cells grown at a density of 5000 cells/cm 2 . Cells were treated with retinol at concentrations of 10 nmol/L, 100 nmol/L and 1 mol/L in the media for 9 d. Values are means Ϯ SD of three replicate assays; *significantly different from control, P Ͻ 0.05.
(P Ͻ 0.05) of all-trans-, 9-cis-and 13-cis-retinoic acid were observed on the growth inhibition of MCF-7 cells and growth stimulation of MDA-MB-231 cells. These data are not represented here because similar results have previously been published elsewhere (Marth et al. 1993 , Van heusden et al. 1998 .
Effect of cell concentration and growth on carotenoid-and retinoid-induced growth inhibition. Several of the growth experiments were also conducted at high and low initial densities of MCF-7 cells. Figure 4A shows the growth of the cells treated with ␤-carotene and all-t-RA, when grown at a high initial density (15,000 cells/cm 2 ). ␤-Carotene and all-t-RA at 10 and 1 mol/L, respectively, did not inhibit growth under these conditions, whereas these concentrations significantly reduced the cell growth when the initial cell density was 5000 cells/cm 2 (Figs. 1, 4 ). In the control cultures of MCF-7 cells, a rapid increase in cell proliferation was observed between d 5 and 9 of growth. The cells grew from ϳ8 ϫ 10 5 cells/well on d 5 to ϳ5 ϫ 10 6 cells/well on d 9 (not shown). To determine whether the growth inhibitory effect of all-t-RA was due to the rapid cell doubling between these two time points, one set of cells was treated with 1 mol/L all-t-RA from d 5 onward and compared with another set of cells supplemented with 1 mol/L all-t-RA from d 1 onward. The cell numbers in the group supplemented from d 5 onward were not different from the control group (Fig. 4B ), indicating that an accumulation of retinoic acid in the cells before this time point is necessary for the retinoid to be effective. The other possibility could be that the cell density on d 5 was too large for the retinoid to have an effect. Effect of all-t-RA on the expression of RAR. The expression of RAR␣ and ␥ in MCF-7 cells as a result of all-t-RA treatment is shown in Figure 5 . Cells were treated with 1 mol/L all-t-RA for 2, 6, 8, 24 or 72 h and investigated for the induction of retinoid receptors at the mRNA level using Northern blot analysis. The bands were compared using densitometric scanning after normalizing with the pHE7 control to determine the fold induction under retinoid treatment ( Table 1) . Small inductions of RAR␣ and ␥ were observed at some time points, but these inductions were not consistent. Similar results of Northern blot analysis were observed in Hs578T cells (Fig. 5 and Table 1 ) using similar treatments and duration. RAR(␣, ␤ and ␥) were not found to be induced consistently. Similarly, no induction of retinoic acid receptors was found at the protein level in MCF-7 and Hs578T cells treated with 1 mol/L all-t-RA using Western blot analysis (data not shown).
Effect of all-t-RA on the cell cycle stage distribution. Figure 6 shows the cell cycle distribution of Hs578T cells treated with 1 mol/L all-t-RA for 6 and 9 d. A significant increase in cell number in the G0/G1 stage of the cell cycle after treatment with all-t-RA was observed for d 6 and 9. No increase was observed for MCF-7 cells under similar conditions (data not shown). (Table 1 ). The observed induction of receptors due to retinoid treatment was not found to be consistent in other replicate analyses.
Effect of all-t-RA on the induction of apoptosis. Chromatin condensation was used as the criterion to determine the induction of apoptosis in the cells as a result of all-t-RA treatment. MCF-7 cells did not contain fragmented nuclei, a marker of apoptosis, when treated with 1 and 10 mol/L all-t-RA for 7 d and stained with acridine orange and propidium iodide for fluorescent microscopy (data not shown). However, all-t-RA treatment induced necrosis in the cells on the basis of orange-red staining of the cells. Orange cells with no nuclear fragmentation were considered dead and counted against live green cells as a marker for necrosis. All-t-RAinduced necrosis was significant (P Ͻ 0.05) and dose dependent in MCF-7 cells ( Table 2) .
DISCUSSION
Numerous studies have been conducted in recent years to evaluate the potential role of vitamin A in the prevention of breast cancer (Hunter and Willett 1994) . The results of both case-control and prospective studies have shown a risk reduction associated with diets high in vitamin A. Retinoids including all-trans-, 9-cis-and 13-cis retinoic acid have been studied by various investigators using cancer cells in culture as model systems of breast cancer (Prakash et al. 2000) . Few investigators have tried to study the role of other retinoids, and to an even lesser extent, carotenoids, for their effects on breast cancer cell growth in culture.
The growth assays conducted in this study were based on the time required for control cultures to reach confluency (d 9) at an initial seeding density of 5000 cells/cm 2 . Until d 9, cells demonstrated normal cell morphology as determined by phase contrast microscopy. Beyond this point, a change in the cell morphology and a rapid increase in cell detachment were observed. Therefore, d 9 was determined to be the point of termination of these growth studies. The cells were counted in both control and treatment cultures on d 2, 5 and 9. The cells that die during culture detach from the plastic of the culture plates and are automatically removed when the growth medium is changed. Hence, the cells counted at these time points were actually the proliferating viable cells attached to the plates. The results demonstrate that the number of these proliferating viable cells was altered in treatment groups compared with control groups on d 9 of treatment. The inhibitory treatments led to more cell detachment from the plastic and hence a lower cell count. Growth inhibition was observed to be maximal at d 9 of treatment; therefore the data are shown for this time point only.
Tetrahydrofuran (0.1%) and acetone (0.25%) were used in 1 MCF-7 and Hs578T cells were treated with 1 mol/L all-transretinoic acid for 2, 6, 8, 24 or 72 h and investigated for the induction of retinoid receptors (RAR␣, ␤ and ␥) at the mRNA level using Northern blot analysis (Fig. 5) .
2 The density of the bands was determined using densitometric scanning. The values obtained were normalized with the values obtained for pHE7 control to determine the fold induction under retinoid treatment.
3 A small induction of the retinoid receptor subtypes was observed at some time points, but this induction was not consistent. this study to deliver carotenoids and retinoids to the cells and were not found to be toxic to the cells (data not shown). Carotenoids and retinoids were supplied to the cells every other day in this study. Other investigations, however, have used from 1 (Zhu et al. 1997 ) to 4 d (Shultz et al. 1992 ) as the time period between feeding the cells. Similarly, the entire duration of treatment before determining the effects on cell growth also differs among studies. The reported duration of treatment has varied from 3 (Kaleagasioglu et al. 1993 ) to 13 d (Shultz et al. 1992) .
␤-Carotene at 10 mol/L is similar to the concentration found in the sera of humans supplemented with ␤-carotene (Nierenberg et al. 1991) . In general, concentrations of 1 and 10 mol/L for retinoids and carotenoids, respectively, resulted in maximum inhibition of cell growth in this study. This is consistent with other studies in which retinoids have been used at varying levels, with the 1 mol/L dose resulting in maximum growth cessation (Chen et al. 1997 , Fanjul et al. 1996 , Marth et al. 1993 , Van heusden et al. 1998 , Zhao et al. 1995 , Zhu et al. 1997 . The growth inhibitory effect of lycopene in MCF-7 cells (at 10 mol/L) observed in this study, however, was markedly less than that observed by Levy et al. (1995) (0.3 mol/L), possibly due to the different culture conditions and the assay used.
A significant effect (P Ͻ 0.05) of all-trans-and 9-cisretinoic acid was observed on the growth inhibition of Hs578T cells (Fig. 2) . Similarly, there was a significant effect (P Ͻ 0.05) of all-trans-, 9-cis-and 13-cis-retinoic acid on the growth inhibition of MCF-7 cells and growth stimulation of MDA-MB-231 cells. These data are not presented here, however, because similar results have previously been published elsewhere (Marth et al. 1993 , Van heusden et al. 1998 ). On the basis of a report by Repa et al. (1993) that indicated that all-trans-retinol is a ligand for the RAR and only four-to sevenfold less potent than all-t-RA in binding to RAR(␣, ␤ and ␥) proteins in competitive binding assays, we set out to test the efficacy of this compound on the growth of MCF-7, Hs578T and MDA-MB-231 cell lines. We found that a 1 mol/L dose of all-trans-retinol induced growth inhibition almost similar to that observed with the same dose of all-t-RA in both MCF-7 (not shown) and Hs578T cells.
The initial cell density appears to be of paramount importance in determining the effects of carotenoids and retinoids on cell proliferation. In the series of growth experiments conducted in our laboratory, we found that the cells must be at an appropriate density to be sensitive to retinoid and carotenoid treatments. When the starting cell numbers of MCF-7 cells were increased to ϳ15,000 cells/cm 2 (Fig. 4) , neither ␤-carotene nor all-t-RA inhibited growth at concentrations of 10 and 1 mol/L, respectively. However, significant growth inhibition was achieved using the same levels of these compounds when the starting cell numbers were reduced to almost one third (Figs. 1, 4) . We also observed that an uptake of all-t-RA by the cells in the early phase of cell culture is essential for this retinoid to inhibit growth. Cells treated with retinoic acid from the middle phase of culture, i.e., when the cells achieved a count of ϳ98,000 cells/cm 2 , showed no growth inhibition (Fig. 4) .
Among patients with breast cancer, tumors that express estrogen receptors (ER) are associated with improved survival and better response to hormone therapy than those not expressing these receptors (Rutqvist 1990) . Despite the general observation that ER(Ϫ) breast cancer cells are not sensitive to retinoids (Lacroix and Lippman 1980, van den Burg et al. 1993) , the growth of ER(Ϫ) Hs578T cells was inhibited by all-trans-and 9-cis-retinoic acid as well as by ␤-carotene in this investigation. Thus, breast cancer cells may be sensitive to carotenoid and retinoid treatments irrespective of their ER status.
Retinoids exert their modulatory effects on cell growth by binding to the nuclear retinoid receptor proteins, of which there are two classes, the RAR and the retinoid X receptor (RXR), each of which has three subtypes (␣, ␤ and ␥). Retinoic acid is thought to first bind to its nuclear receptors; this ligand-receptor complex in the form of homodimers or heterodimers then binds to its respective response elements (retinoic acid response elements) in the promoters of a variety of retinoic acid-responsive genes. Binding of the natural retinoids all-t-RA and 9-cis-retinoic acid to the retinoid receptors enhances receptor responses (Allenby et al. 1993 , Heyman et al. 1992 , Levin et al. 1992 . The RAR bind to both all-t-RA and 9-cis-retinoic acid with high affinity, whereas RXR bind to 9-cis-retinoic acid only (Heyman et al. 1992 , Levin et al. 1992 . RXR play an extremely important role in mediating retinoic acid and vitamin D effects at the level of gene expression by forming heterodimers with RAR and vitamin D receptor, respectively (Zhao et al. 1995) .
The Northern blot analyses revealed that all three cell lines used in this study express basal levels of RAR␣ and ␥, whereas only Hs578T cells express RAR␤. The level of the basal expression of these receptor subtypes was also variable in the three cell lines. We did not observe a consistent induction of any of the RAR subtypes in MCF-7 and Hs578T cells either at the mRNA level using Northern blot analysis (Fig. 5) or at the protein level using Western blot analysis (data not shown).
Several studies have tried to correlate the retinoid receptors to the retinoid sensitivity, and a majority of these studies have used different receptor-selective retinoids for this purpose. RAR␣-selective retinoid agonists inhibited the anchoragedependent growth of MCF-7 cells after a 7-d treatment, suggesting that RAR␣ is the retinoid receptor involved in the inhibition of adherent cell growth by retinoids (Dawson et al. 1995) . In another study, retinoic acid strongly inhibited the proliferation of ER(ϩ) MCF-7 cells but not of ER(Ϫ) Hs578T and MDA-MB-231 cells, and RAR␣ mRNA was highly expressed in the RA-responsive lines, but not in the unresponsive lines (van den Burg et al. 1993) . The authors suggested that the loss of functional RAR may be a frequent event, leading to RA unresponsiveness of ER(Ϫ) breast cancer cells. RAR␤-negative cell lines MCF-7 and MDA-MB-231 underwent growth inhibition associated with G1 arrest when treated with 1 mol/L all-t-RA after a human RAR␤ gene was introduced into these cell lines using a retroviral vector-mediated gene transduction (Seewaldt et al. 1995) . Similarly, RAR␤ induction in MCF-7 cells by all-t-RA was demonstrated using different receptor-selective retinoids. By using an RAR␣-selective antagonist (Ro 41-5253), RAR␤ expression was induced by all-t-RA through an RAR␣-dependent signaling pathway in MCF-7 cells (Shang et al. 1999) . Receptor selective retinoids induced apoptosis in MCF-7 cells, indicating that RAR␣, RAR␥ and RXR␣ can mediate programmed cell death (Toma et al. 1998) . These observations, which have followed an indirect approach of relating retinoid receptors to the cell growth inhibitory mechanism, suggest the involvement of all three subtypes of RAR in the growth inhibition of breast cancer cells. The results of our study, which involved a direct method of determining the expression of RAR as a result of treatment with their natural ligand all-t-RA, indicate that altering RAR expression is not involved in the growth inhibition of breast cancer cells caused by this retinoid. Similarly, RAR␥ selectively binding retinoids (CD2325, CD666 and CD437) inhibited the proliferation of MCF-7 cells similar to all-t-RA and no correlation was found between expression of RAR and antiproliferative effects of the retinoids (Widschwendter et al. 1997) .
The flow cytometry results of this investigation indicate an arrest of Hs578T cells in the G0/G1 stage of the cell cycle as a result of all-t-RA treatment (Fig. 6) . The same effect was not observed for MCF-7 cells. It is possible that all-t-RA induces the expression of G0/G1-specific gene(s) in Hs578T cells, which were not assessed in this study. Apoptotic induction as a result of all-t-RA treatment was not observed in MCF-7 cells because the morphological nuclear fragmentation did not occur. The use of more sensitive techniques for the determination of early apoptosis, such as Annexin V or BRDU staining methods, may provide greater insight into retinoid-induced apoptosis in these cells. There was, however, a dose-dependent necrotic death observed in MCF-7 cells induced by all-t-RA (Table 2 ) on the basis of the accumulation of fluorescent dyes in the cells (Broaddus et al. 1996) as explained in Materials and Methods.
The overall results of our study demonstrate that carotenoids and retinoids inhibit the growth of both ER(ϩ) and ER(Ϫ) breast cancer cell lines, indicating that estrogen receptor status is an important, although not essential factor for the responsiveness of breast cancer cells to carotenoid and retinoid treatments. Also, the mechanism behind growth inhibition of ER(ϩ) MCF-7 and ER(Ϫ) Hs578T cells by all-t-RA does not involve transcriptional modulation of the RAR by this retinoid. We are convinced, however, that the mode of action of carotenoids and retinoids in breast cancer cells should not be considered to be limited to the enhancement of basal expression of retinoid receptors (both RAR and RXR series) as a result of treatment. Other mechanistic pathways that are either followed by or concomitant with growth inhibition are possible, including the induction of activation protein-1-responsive genes and the cell cycle-specific genes.
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